EXR
26
2
NDAQ
77
3
HRL
35
12
ES
45
-4
SBUX
40
-4
ALLE
46
2
KMX
38
-9
ECL
62
5
VTR
69
2
TXN
52
2
MTB
75
2
LH
48
5
KSS
58
-4
SWK
61
6
PGR
44
2
WHR
48
-2
AON
65
3
BF.B
39
-3
PH
64
2
FITB
78
3
EXR
26
2
NDAQ
77
3
HRL
35
12
ES
45
-4
SBUX
40
-4
ALLE
46
2
KMX
38
-9
ECL
62
5
VTR
69
2
TXN
52
2
MTB
75
2
LH
48
5
KSS
58
-4
SWK
61
6
PGR
44
2
WHR
48
-2
AON
65
3
BF.B
39
-3
PH
64
2
FITB
78
3
Financhill
Back

Freeport-McMoRan, Inc. Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Buy
75

FCX
Freeport-McMoRan, Inc.

Last Price:
$51.46
Seasonality Move:
7.92%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$32.38
Seasonality Move:
-10.99%
Buy
75
Freeport-McMoRan, Inc. (FCX) is a Buy

Is Freeport-McMoRan, Inc. a Buy, Sell or Hold?

  • The current Freeport-McMoRan, Inc. [FCX] share price is $50.64. The Score for FCX is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • FCX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FCX Stock Price Chart

What is Freeport-McMoRan, Inc.'s stock price today?

  • The Freeport-McMoRan, Inc. share price today is $50.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCX is experiencing slight buying pressure.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

FCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.04 Buy
Relative Strength Index (14 RSI): 78.53 Buy
Chaikin Money Flow: 6185561 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.09 - 47.67) Buy
Bollinger Bands (100): (39.72 - 45.44) Buy

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

FCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.26 Buy
20-day SMA: 45.49 Buy
50-day SMA: 42.75 Buy
200-day SMA: 41.1 Buy
8-day EMA: 48.2 Buy
20-day EMA: 46.03 Buy
50-day EMA: 43.86 Buy
200-day EMA: 42.16 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

Freeport-McMoRan, Inc. Earnings Growth & FCX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.73 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

Freeport-McMoRan, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):